Henry Schein FY2024 EPS Forecast Increased by William Blair

Henry Schein, Inc. (NASDAQ:HSIC) – Investment analysts at William Blair raised their FY2024 earnings per share estimates for shares of Henry Schein in a research note issued on Tuesday, November 5th. William Blair analyst B. Vazquez now expects that the company will earn $4.78 per share for the year, up from their prior estimate of $4.74. The consensus estimate for Henry Schein’s current full-year earnings is $4.76 per share. William Blair also issued estimates for Henry Schein’s Q2 2025 earnings at $1.30 EPS, Q3 2025 earnings at $1.30 EPS and FY2026 earnings at $5.59 EPS.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Tuesday, November 5th. The company reported $1.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.17 by $0.05. The firm had revenue of $3.17 billion for the quarter, compared to the consensus estimate of $3.24 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business’s revenue for the quarter was up .4% on a year-over-year basis. During the same period in the prior year, the company posted $1.32 earnings per share.

A number of other equities research analysts also recently weighed in on the company. UBS Group reduced their target price on Henry Schein from $75.00 to $72.00 and set a “neutral” rating on the stock in a report on Wednesday, August 7th. Robert W. Baird decreased their target price on Henry Schein from $92.00 to $82.00 and set an “outperform” rating on the stock in a research report on Wednesday, August 7th. Evercore ISI raised their price target on shares of Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a research note on Tuesday, October 8th. StockNews.com upgraded shares of Henry Schein from a “sell” rating to a “hold” rating in a research report on Thursday. Finally, JPMorgan Chase & Co. cut their target price on shares of Henry Schein from $88.00 to $80.00 and set an “overweight” rating on the stock in a research report on Monday, August 12th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $77.50.

Henry Schein Stock Performance

NASDAQ HSIC opened at $68.00 on Friday. The firm’s 50 day simple moving average is $70.51 and its 200 day simple moving average is $69.73. The firm has a market capitalization of $8.48 billion, a price-to-earnings ratio of 27.98, a P/E/G ratio of 2.00 and a beta of 0.87. The company has a current ratio of 1.42, a quick ratio of 0.90 and a debt-to-equity ratio of 0.46. Henry Schein has a 1 year low of $62.12 and a 1 year high of $82.63.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Cromwell Holdings LLC increased its position in shares of Henry Schein by 93.4% during the third quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock worth $26,000 after buying an additional 170 shares during the period. Summit Securities Group LLC acquired a new stake in Henry Schein during the 2nd quarter worth about $31,000. Beach Investment Counsel Inc. PA bought a new position in shares of Henry Schein in the 2nd quarter worth about $37,000. Blue Trust Inc. lifted its stake in shares of Henry Schein by 104.2% in the 2nd quarter. Blue Trust Inc. now owns 931 shares of the company’s stock valued at $60,000 after purchasing an additional 475 shares during the period. Finally, Farther Finance Advisors LLC boosted its position in shares of Henry Schein by 58.9% during the 3rd quarter. Farther Finance Advisors LLC now owns 933 shares of the company’s stock valued at $68,000 after purchasing an additional 346 shares in the last quarter. Institutional investors and hedge funds own 96.62% of the company’s stock.

Insider Activity at Henry Schein

In other Henry Schein news, SVP Lorelei Mcglynn sold 21,035 shares of the company’s stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $69.30, for a total value of $1,457,725.50. Following the sale, the senior vice president now owns 71,833 shares in the company, valued at approximately $4,978,026.90. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. 1.14% of the stock is currently owned by company insiders.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.